Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 30
- 试验地点
- 2
- 主要终点
- Percentage of patients who agreed to participate in research
研究概览
简要总结
In this research, we will evaluate the feasibility of following by remote monitoring, using a connected scale, in hematology patients suffering from myeloma or lymphoma and requiring treatment with chemotherapy. 30 patients will be included in the research and will all use a connected scale for the duration of their participation (7 weeks +/- 1 week). During their participation, patients will be asked to weigh themselves once a day, ideally at a set time. Patient data will be accessible by the medical team via a remote monitoring platform.
Alerts will be generated in the event of abnormal development of certain clinical parameters (weight, heart rate, etc.) allowing early treatment to be implemented by the medical team.
At the end of their participation, we will evaluate patients' support and perception of this tool, as well as the healthcare consequences of the alerts generated by the remote monitoring platform.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient aged 18 and over (male or female)
- •Patient suffering from aggressive non-Hodgkin's lymphoma or multiple myeloma with a plan for systemic chemotherapy or having started two cycles or less or patient with the need for therapeutic intensification under the cover of autograft in the context of myeloma or lymphoma
- •Patient who can be contacted by telephone during their participation in the research
- •Patient able to return home at the end of their initial hospitalization
- •Patient affiliated to social security
- •Patient able to read and speak French
- •Patient having signed free, informed and written consent
排除标准
- •Patient with an estimated life expectancy < 3 months
- •Patient with moderate to severe cognitive impairment (assessed by MMSE < 20)
- •Patient with a psychiatric or physical disability that does not allow the use of the device
- •Patient with a pacemaker
- •Patient participating in another intervention research project
- •Pregnant patient
- •Patient deprived of liberty
- •Patient under legal protection (guardianship or curatorship)
结局指标
主要结局
Percentage of patients who agreed to participate in research
时间窗: Inclusion
Number of included patients / Number of indormed patients
次要结局
- Evaluation of the ease of use of the device perceived by the patient(week 7)
- Assessment of the patient's anxiety regarding the device(week 7)
- Evaluation of the implementation of the study by the patient(week 7)
- Frequency of use of the connected scale during the patient's participation in the research(From inclusion to week 7)
- Evaluation of the consequences in care of alerts generated by the plateform(From inclusion to week 7)